Cadrenal Therapeutics, Inc. Common Stock Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$1.28 | -$1.28 | -$1.28 |
| Q2 2024 | 3 | -$2.53 | -$0.95 | -$1.93 |
| Q3 2024 | 1 | -$2.03 | -$2.03 | -$2.03 |
| Q1 2025 | 2 | -$1.50 | -$1.50 | -$1.50 |
| Q2 2025 | 2 | -$1.05 | -$1.05 | -$1.05 |
| Q3 2025 | 2 | -$1.20 | -$1.20 | -$1.20 |
| Q4 2025 | 2 | -$1.20 | -$1.20 | -$1.20 |
Cadrenal Therapeutics, Inc. Common Stock Earnings Date And Information
Cadrenal Therapeutics, Inc. Common Stock last posted its earnings results on Wednesday, August 7th, 2024. The company reported $-2.25 earnings per share for the quarter, topping analysts' consensus estimates of $-19.04 by $16.79. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Cadrenal Therapeutics, Inc. Common Stock has generated $-10 earnings per share over the last year ($-9.63 diluted earnings per share) and currently has a price-to-earnings ratio of -2.5. Cadrenal Therapeutics, Inc. Common Stock has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 7th, 2024 based on prior year's report dates.
Cadrenal Therapeutics, Inc. Common Stock Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/07/2024 | Q2 2024 | -$19.04 | -$2.24 | 16.8 | $0 | $0 |
| 05/09/2024 | Q1 2024 | -$0.07 | -$1.55 | -1.48 | $0 | |
| 03/08/2024 | Q4 2023 | -$0.09 | -$1.32 | -1.23 | $2,768 | |
| 11/09/2023 | Q3 2023 | -$1.19 | $0 | |||
| 08/10/2023 | Q2 2023 | -$1.28 | $0 | |||
| 05/10/2023 | Q1 2023 | -$6.62 | $0 | |||
| 03/29/2023 | Q4 2022 | -$6.46 | $0 | |||
| 09/29/2022 | Q3 2022 | -$0.09 | $0 | |||
| 06/30/2022 | Q2 2022 | -$0.04 | $0 | |||
| 03/31/2022 | Q1 2022 | -$0.02 | $0 |
Cadrenal Therapeutics, Inc. Common Stock Earnings: Frequently Asked Questions
-
When is Cadrenal Therapeutics, Inc. Common Stock's earnings date?
Cadrenal Therapeutics, Inc. Common Stock has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 7th, 2024 based off last year's report dates.
-
Did Cadrenal Therapeutics, Inc. Common Stock beat their earnings estimates last quarter?
In the previous quarter, Cadrenal Therapeutics, Inc. Common Stock (:CVKD) reported $-2.25 earnings per share (EPS) to beat the analysts' consensus estimate of $-19.04 by $16.79.
-
How can I listen to Cadrenal Therapeutics, Inc. Common Stock's earnings conference call?
The conference call for Cadrenal Therapeutics, Inc. Common Stock's latest earnings report can be listened to online.
-
How can I read Cadrenal Therapeutics, Inc. Common Stock's conference call transcript?
The conference call transcript for Cadrenal Therapeutics, Inc. Common Stock's latest earnings report can be read online.
-
How much profit does Cadrenal Therapeutics, Inc. Common Stock generate each year?
Cadrenal Therapeutics, Inc. Common Stock (:CVKD) has a recorded net income of $0. Cadrenal Therapeutics, Inc. Common Stock has generated $-9.63 earnings per share over the last four quarters.
-
What is Cadrenal Therapeutics, Inc. Common Stock's price-to-earnings ratio?
Cadrenal Therapeutics, Inc. Common Stock (:CVKD) has a price-to-earnings ratio of -2.5 and price/earnings-to-growth ratio is 0.14.
